Ashish Yadav·Oct 23A Practical Architecture for AI Assisted Medical Legal and Regulatory ReviewMedical, legal, and regulatory review depends on the relationship between a claim and its evidence. A sentence may be accurate in isolation…
InZS AssociatesbyZS·Aug 11How medical affairs can strengthen access before launchMedical affairs has always helped communicate science. The launch access challenge now is whether it can help turn that science into…
Kanwalsingh·Jul 22Clinical Trial Data: Structure, CDISC Standards, And Analytics Use CasesHere is a common experience for commercial pharma analysts: you are in a cross functional meeting with medical affairs colleagues, and…A response icon1A response icon1
Pharma Field Note·Feb 28How I Entered the Pharmaceutical Industry — When an Opportunity Met TimingA story about being chosen for usefulness — and staying long enough to understand why
Oliver Mende·Jan 21Beyond Silos: Building Compliant Data Ecosystems in PharmaThe Challenge Pharma Faces
InZS AssociatesbyPeter MacLean·Dec 15, 2025The credibility crisis: How AI is reshaping entry-level medical affairsMedical affairs leaders is facing a talent development problem, can AI help?A response icon1A response icon1
Andrew Burak·Nov 18, 2025AI in Pharma: From Theory to Practice in Medical AffairsAI has been a big promise in pharma for years, but most of it stayed in slide decks. Everyone talks about the potential, yet only a handful…A response icon1A response icon1
Justin Kulovsek·Sep 21, 2025Why Medical Affairs Needs an Always-On Omnichannel Strategy for Scientific ExchangeMoving beyond congress cycles to deliver credible science year-round
Justin Kulovsek·Jun 10, 2025Omnichannel: Why Medical Affairs Needs a Digital Rethink (Yes, You Too)Let’s face it — Commercial has dominated omnichannel.
